Literature DB >> 19330876

The Cobas AmpliPrep-Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples.

Stéphane Chevaliez, Magali Bouvier-Alias, Laurent Castéra, Jean-Michel Pawlotsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19330876     DOI： 10.1002/hep.22767

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  12 in total

Review 1.  New virologic tools for management of chronic hepatitis B and C.

Authors:  Stéphane Chevaliez; Christophe Rodriguez; Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

2.  Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.

Authors:  Johannes Vermehren; Giuseppe Colucci; Peter Gohl; Nabila Hamdi; Ahmed Ihab Abdelaziz; Ursula Karey; Diana Thamke; Heike Zitzer; Stefan Zeuzem; Christoph Sarrazin
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

3.  Hepatitis C virus genotype 2 may not be detected by the Cobas AmpliPrep/Cobas TaqMan HCV Test, Version 1.0.

Authors:  Tsunamasa Watanabe; Takako Inoue; Yasushi Tanoue; Hisato Maekawa; Susumu Hamada-Tsutsumi; Shinsho Yoshiba; Yasuhito Tanaka
Journal:  J Clin Microbiol       Date:  2013-09-25       Impact factor: 5.948

Review 4.  Hepatitis C virus: Virology, diagnosis and treatment.

Authors:  Hui-Chun Li; Shih-Yen Lo
Journal:  World J Hepatol       Date:  2015-06-08

5.  The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.

Authors:  Stéphane Chevaliez; Magali Bouvier-Alias; Christophe Rodriguez; Alexandre Soulier; Jean-Dominique Poveda; Jean-Michel Pawlotsky
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

6.  Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.

Authors:  Sylvie Larrat; Jean-Dominique Poveda; Camille Coudret; Katia Fusillier; Nelly Magnat; Anne Signori-Schmuck; Vincent Thibault; Patrice Morand
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

Review 7.  Treatment of hepatitis C: how will we use viral kinetics, response-guided therapy?

Authors:  Jean-Michel Pawlotsky
Journal:  Curr Gastroenterol Rep       Date:  2013-02

8.  Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification.

Authors:  Stéphane Chevaliez; Magali Bouvier-Alias; Jean-Michel Pawlotsky
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

9.  APASL consensus statements and management algorithms for hepatitis C virus infection.

Authors:  Masao Omata; Tatsuo Kanda; Ming-Lung Yu; Osamu Yokosuka; Seng-Gee Lim; Wasim Jafri; Ryosuke Tateishi; Saeed S Hamid; Wan-Long Chuang; Anuchit Chutaputti; Lai Wei; Jose Sollano; Shiv Kumar Sarin; Jia-Horng Kao; Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2012-03-01       Impact factor: 9.029

10.  A novel duplex real-time reverse transcriptase-polymerase chain reaction assay for the detection of hepatitis C viral RNA with armored RNA as internal control.

Authors:  Shuang Meng; Jinming Li
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.